<DOC>
	<DOCNO>NCT01994486</DOCNO>
	<brief_summary>This open-label , multi center study treatment-naive non-cirrhotic subject genotype 1 chronic Hepatitis C Virus . All subject receive telaprevir ( TVR ) combination sofosbuvir ( SOF ) 12 week .</brief_summary>
	<brief_title>Open-Label Safety Study Telaprevir Sofosbuvir Chronic Hepatitis C Genotype 1</brief_title>
	<detailed_description>Starting Day 1 12 week , receive Telaprevir ( TVR ) Sofosbuvir ( SOF ) . You take one ( 1 ) 400 mg tablet SOF 3 tablet ( 1125 mg ) TVR . You take together mouth every morning . You take another 3 tablet ( 1125 mg ) TVR mouth 12 hour take morning dose .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Willing able provide inform consent BMI ( Body Mass Index ) ≥ 18 kg/m2 HCV RNA quantifiable screen &gt; 1,000 IU/ml HCV treatment Naïve HCV genotype 1 7 . Confirmation chronic HCV infection document either : A positive antiHCV antibody test positive HCV RNA positive HCV genotyping test least 6 month prior Baseline/Day 1 visit , A liver biopsy perform prior Baseline/Day 1 visit evidence chronic HCV infection Current prior history follow : Clinicallysignificant illness Cirrhosis 2 . Screening ECG clinically significant abnormality 1 . ALT &gt; 10 x upper limit normal ( ULN ) 2 . AST &gt; 10 x ULN 3 . Direct bilirubin &gt; 1.5 x ULN 4 . Platelets &lt; 150,000/μL 5 . HbA1c &gt; 7.5 % 6 . Creatinine clearance ( CLcr ) &lt; 60 mL /min , calculate CockcroftGault equation 7 . Hemoglobin &lt; 11 g/dL female subject ; &lt; 12 g/dL male subject . 8 . Albumin &lt; 3.1 g/dL 9 . INR &gt; 1.5 x ULN unless subject know hemophilia stable anticoagulant regimen affect INR 4 . Prior exposure approve experimental HCVspecific directacting 5 . Pregnant nursing female male pregnant female partner . 6 . Chronic liver disease nonHCV etiology ( e.g. , hemochromatosis , Wilson 's disease , alfa1 antitrypsin deficiency , cholangitis ) . 7 . Infection hepatitis B virus ( HBV ) human immunodeficiency virus ( HIV ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>HCV Genotype 1</keyword>
	<keyword>Hepatitis C Virus Genotype 1</keyword>
	<keyword>HCV</keyword>
	<keyword>TVR</keyword>
</DOC>